EMD 6.25% 3.4¢ emyria limited

Ann: Dosing Commences For EMD-RX5 Phase 1 Human Clinical Trial, page-2

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,762 Posts.
    lightbulb Created with Sketch. 179
    "Pivotal Phase III trial design and planning completed, expected to commence
    immediately following the successful completion of the Phase 1 study"

    Hopefully this gives it a BOOT.
 
watchlist Created with Sketch. Add EMD (ASX) to my watchlist
(20min delay)
Last
3.4¢
Change
0.002(6.25%)
Mkt cap ! $14.12M
Open High Low Value Volume
3.4¢ 3.6¢ 3.4¢ $8.332K 243.9K

Buyers (Bids)

No. Vol. Price($)
4 208187 3.2¢
 

Sellers (Offers)

Price($) Vol. No.
3.6¢ 235000 2
View Market Depth
Last trade - 16.10pm 15/11/2024 (20 minute delay) ?
EMD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.